BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7040086)

  • 21. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
    Verhoef J; Rozenberg-Arska M; Dekker A
    Haematol Blood Transfus; 1987; 30():188-93. PubMed ID: 3114058
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-trimoxazole from the therapeutic viewpoint.
    Lode H
    Infection; 1987; 15 Suppl 5():S222-6. PubMed ID: 3325432
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of bacterial infections].
    Siegenthaler W; Fuchs P; Lüthy R
    Internist (Berl); 1981 Feb; 22(2):57-61. PubMed ID: 7012069
    [No Abstract]   [Full Text] [Related]  

  • 27. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
    Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
    Infection; 1986; 14(6):261-7. PubMed ID: 3546144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
    König U; Müller U; Binswanger U
    Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of infections in granulocytopenia patients with a brulamycin-bactrim combination].
    Magyar T; Graber H; Arr M; Csiba A; Kelemen E; Péterfy M; Jánossa M
    Orv Hetil; 1985 Sep; 126(35):2165-8. PubMed ID: 3875821
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of febrile episodes in neutropenic patients.
    Melikian V; Falk R
    Scott Med J; 1976 Apr; 21(2):73-4. PubMed ID: 940999
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
    Bow EJ; Rayner E; Louie TJ
    Am J Med; 1988 May; 84(5):847-54. PubMed ID: 3284340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
    Wade JC; Schimpff SC; Hargadon MT; Fortner CL; Young VM; Wiernik PH
    N Engl J Med; 1981 Apr; 304(18):1057-62. PubMed ID: 6782486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.
    Guiot HF; van Furth R
    Infection; 1984; 12(1):1-4. PubMed ID: 6423548
    [No Abstract]   [Full Text] [Related]  

  • 34. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.
    Cohen J; Donnelly JP; Worsley AM; Catovsky D; Goldman JM; Galton DA
    Lancet; 1983 Dec 24-31; 2(8365-66):1452-4. PubMed ID: 6140545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
    Meunier-Carpentier F; Cruciani M; Klastersky J
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):43-8. PubMed ID: 6303794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of surveillance stool cultures during periods of severe neutropenia.
    Wells CL; Ferrieri P; Weisdorf DJ; Rhame FS
    Infect Control; 1987 Aug; 8(8):317-9. PubMed ID: 3308740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intestinal decontamination in the neutropenic patient. Apropos of a prospective randomized study].
    Pellegrin JL; Fourche J; Marit G; David B; Texier J; Reiffers J; Leng B; Broustet A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):676-9. PubMed ID: 3095780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversies in the management of febrile neutropenic cancer patients.
    Rubin M; Hathorn JW; Pizzo PA
    Cancer Invest; 1988; 6(2):167-84. PubMed ID: 3132310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.